Novonix Current Deferred Revenue from 2010 to 2025
| NVX Stock | USD 1.03 0.01 0.98% |
Current Deferred Revenue | First Reported 2017-03-31 | Previous Quarter 126.1 K | Current Value 3.5 M | Quarterly Volatility 2.8 M |
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Other Operating Expenses of 60.2 M, Total Operating Expenses of 58.4 M or Depreciation And Amortization of 4.8 M, as well as many indicators such as Price To Sales Ratio of 59.26, Dividend Yield of 0.0167 or PTB Ratio of 2.79. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
Novonix | Current Deferred Revenue | Build AI portfolio with Novonix Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novonix Stock Analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.